Study at a glance
How does vitamin D-binding protein carry vitamin D in the blood?
This page explains how vitamin D-binding protein carries forms of vitamin D in blood. It combines studies of the protein’s structure, mouse experiments, kidney studies and one rare human case. These different types of evidence help explain the carrier’s role and its limits.
What happened to mice that could not make vitamin D-binding protein?
The protein attaches strongly to vitamin D forms and helps keep them in the blood for longer. Mice unable to make this protein had very low total vitamin D blood measurements. They remained broadly normal when vitamin D supply was adequate. When their diet contained less vitamin D, they developed hormone and bone changes sooner.
What did kidney studies and the rare human case show?
Kidneys can recover vitamin D attached to the carrier protein, rather than losing it in urine. This does not mean every organ uses the same process. A woman who could not make the carrier protein had extremely low total vitamin D measurements but normal blood calcium. Her case showed that some vitamin D functions remained despite the missing carrier.
Do total blood levels show all vitamin D activity in tissues?
The carrier helps maintain a supply of vitamin D in blood, but is not required for every vitamin D effect. Mouse experiments and complete loss of the human protein are unusual situations. They do not tell us the size of effects from common inherited differences. Total blood levels do not directly measure all vitamin D activity in tissues.
Read the full article below ↓Vitamin D-binding protein (DBP) is the dominant high-affinity carrier for circulating vitamin D metabolites, but its physiological role is broader than transport from one place to another. Structural, knockout, receptor-pathway and rare-human evidence show that DBP creates a stable circulating reservoir, slows loss of metabolites and can participate in specialised tissue uptake. The same evidence also shows an important limit: DBP is not absolutely required for every biological action of vitamin D. See Full Study.
What is DBP structurally?
Human DBP is encoded by the GC gene and belongs to the albuminoid protein family. X-ray crystallography resolved a three-domain protein with the main vitamin D-binding pocket in domain I. That molecular structure provides a physical explanation for DBP’s high-affinity binding of vitamin D metabolites rather than leaving the carrier relationship as an inference from blood measurements alone.
Why does high-affinity binding matter?
High-affinity binding allows a large total circulating pool of 25-hydroxyvitamin D [25(OH)D] to coexist with a very small free fraction. In this sense DBP acts as a reservoir and buffer. The broader carrier system is explained in Vitamin D Transport Proteins, while Plasma Transport of Vitamin D Metabolites: Evidence Synthesis gives the narrower evidence-based view of how that carrier system shapes plasma persistence.
Targeted DBP-knockout mice show the consequence directly. They have very low total circulating vitamin D metabolites, yet remain broadly normal when vitamin D supply is adequate. DBP markedly prolongs the serum half-life of 25(OH)D and helps maintain stable stores. When dietary vitamin D is restricted, animals without DBP develop secondary hyperparathyroidism and skeletal changes more quickly, showing that the carrier provides reserve when supply falls.
Can cells use vitamin D while it is DBP-bound?
In the renal proximal tubule, yes. Cubilin and megalin participate in receptor-mediated retrieval of DBP-bound 25(OH)D. Dysfunction of this pathway causes urinary loss of vitamin D metabolites and abnormal vitamin D metabolism. This is a strong exception to a simplistic rule that only free vitamin D can ever become available to cells. The organ-level setting is covered in Vitamin D and Kidneys.
The mechanism is tissue-specific. It should not be projected onto every organ. A deeper mechanistic treatment is available in Cellular uptake and intracellular handling of vitamin D metabolites: Full Evidence Review, while Vitamin D Transport and Tissue Delivery: Evidence Synthesis places renal retrieval within the wider question of how carrier-bound and free pools reach different tissues.
What does rare human DBP deficiency show?
A woman with homozygous deletion of the GC gene had no detectable circulating DBP and extremely low total vitamin D metabolite concentrations. Despite that, she maintained normocalcaemia and meaningful vitamin D function. The case confirms in humans that total serum concentration is partly a property of the binding-protein reservoir rather than a direct meter of all tissue action.
What did the different experiments establish?
The evidence is strongest because the studies perform different jobs. Crystallography establishes the physical binding site. The mouse knockout tests what disappears when DBP itself is removed and shows reduced circulating reserve, shorter metabolite persistence and greater vulnerability to deficiency. Cubilin-megalin work establishes a renal route by which a protein-bound metabolite can be recovered rather than lost. The rare human GC deletion then shows that the extreme low-total/highly altered-binding state is possible in people as well as animals.
No single experiment proves the whole transport model. Their agreement across molecular structure, causal knockout, receptor-mediated uptake and human genetics is what makes the overall interpretation strong.
What should the evidence not be taken to mean?
- DBP is not absolutely required for every vitamin D effect.
- Renal megalin-cubilin uptake is not proof that all tissues use the same pathway.
- Rare complete GC deletion and mouse knockout are extreme perturbations and do not quantify ordinary common human polymorphisms.
- A lower total 25(OH)D concentration caused by reduced DBP does not necessarily imply an equally large reduction in free vitamin D or tissue action.
The central point is that DBP changes the size, stability and handling of the circulating vitamin D pool. That is why the relationship described in Free vs Total Vitamin D Explained cannot be understood without transport physiology.
The practical implication is not that serum measurements should be ignored. It is that transport context changes what a measured concentration represents. A large DBP-bound reservoir supports persistence and buffering, while tissue-specific uptake mechanisms determine whether some bound substrate can be actively recovered. The distinction also helps explain why Vitamin D Status vs Vitamin D Effect is broader than any single serum number.
Primary evidence and publication details
A structural basis for the unique binding features of the human vitamin D-binding protein. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C. Nature Structural Biology. 2002;9:131-136.
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. Safadi FF, Thornton P, Magiera H, et al. Journal of Clinical Investigation. 1999;103:239-251.
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Nykjaer A, Dragun D, Walther D, et al. Proceedings of the National Academy of Sciences USA. 2001;98:13895-13900.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine. 2019;380:1150-1157.
Related reading
A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E
A signature of 16 serum proteins that were previously profiled using the aptamer‐based Somascan technology highlighted the roles of the e2 allele of APOE in lipid regulation via apolipoprotein B (APOB) and apolipoprotein E (APOE) and in inflammation.
Original paper ↗Read more →Assessing the influence of maternal vitamin D deficiency in early pregnancy and subsequent improvement on perinatal outcomes and long-term child development: a retrospective cohort study
We evaluated obstetric and neonatal outcomes, including long-term neurodevelopmental assessments.
Original paper ↗Read more →Association of vitamin D-binding protein and vitamin D3 with insulin and homeostatic model assessment (HOMA-IR) in overweight and obese females
This study was conducted to evaluate the relationships among 25(OH)D, VDBP, glucose/insulin metabolism and homeostatic model assessment (HOMA-IR).
Original paper ↗Read more →Biomarkers to predict or measure steroid resistance in idiopathic nephrotic syndrome: A systematic review
Additionally, we aim to select biomarkers that have the best evidence-base and should be prioritised for further research.
Original paper ↗Read more →Comparative iTRAQ proteomics identified proteins associated with sperm maturation between yak and cattleyak epididymis
During maturation, spermatozoa acquire motility and fertilizing capacity as they transit through the epididymis.
Original paper ↗Read more →Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache
Medication Overuse Headache (MOH) is a prevalent and disabling disorder resulting from the overuse of analgesic drugs, triptans or other acute headache medications.
Original paper ↗Read more →Exploring Candidate Gene Studies and Alexithymia: A Systematic Review
Therefore, the aim of the present study was to perform a systematic review of the genetic background associated with alexithymia.
Original paper ↗Read more →Genotype-independent association between vitamin D deficiency and polycystic ovarian syndrome in Lahore, Pakistan
Both vitamin D deficiency and single nucleotide polymorphisms (SNPs) in the gene encoding the vitamin D receptor (VDR) have been widely reported to associate with susceptibility to polycystic ovarian syndrome (PCOS).
Original paper ↗Read more →Identification of protein biomarkers associated with congenital diaphragmatic hernia in human amniotic fluid
The study objective was to identify proteomic changes in amniotic fluid consistently associated with CDH.
Original paper ↗Read more →Integrated plasma and vegetation proteomic characterization of infective endocarditis for early diagnosis and treatment
Infective endocarditis, a life-threatening condition, poses challenges for early diagnosis and personalized treatment due to insufficient biomarkers and limited understanding of its pathophysiology.
Original paper ↗Read more →Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes
Here, we evaluated plasma protein levels from 400 unrelated healthy individuals of western European ancestry, who were stratified by sex and two decades of life (20 to 29 and 60 to 69 years), from the Milieu Intérieur cohort.
Original paper ↗Read more →Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease
Our aim was to determine of the proteomic profile of urine from patients with FSGS and MCD.
Original paper ↗Read more →Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis
Participants were aged 18 to 59 years and had a first demyelinating event during the study recruitment period (1 November 2003 to 31 December 2006) for the Ausimmune Study (n = 216) and had follow-up data to 2 to 3 years post-initial interview.
Original paper ↗Read more →Proteomic Profiling of Pre: and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation
Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor characterized by a high infiltration capability and recurrence rate.
Original paper ↗Read more →Selective EV Protein Sorting and Pathway Perturbation in AML Upon Synergistic FLT3 and Hedgehog Pathway Inhibition
Acute myeloid leukaemia (AML) is a haematologic malignancy with high relapse incidence and mortality.
Original paper ↗Read more →Serum 24,25-dihydroxyvitamin D level in general Korean population and its relationship with other vitamin D biomarkers
The present study aimed to determine the values of 24,25(OH)2D and VMR in healthy Koreans and compare them with other vitamin D biomarkers, including 25(OH)D and bioavailable 25(OH)D.
Original paper ↗Read more →Systematic review of emerging technologies in vascularized composite allotransplantation
VCA has rapidly evolved through novel surgical, immunologic, and bioengineering technologies.
Original paper ↗Read more →Towards harmonization of directly measured free 25-hydroxyvitamin D using an enzyme-linked immunosorbent assay
The availability of a new enzyme-linked immunosorbent assay (ELISA) for the determination of free 25(OH)D provides a method for direct measurement of the low levels of non-protein bound 25(OH)D.
Original paper ↗Read more →Use of milk proteins as biomarkers of changes in the rumen metaproteome of Holstein cows fed low-fiber, high-starch diets
Dietary levels of undegraded neutral detergent fiber (uNDF240) and rumen-fermentable starch (RFS) can affect the rumen microbiome and milk composition.
Original paper ↗Read more →Vitamin D metabolic loci and preeclampsia risk in multi‐ethnic pregnant women
Our objective was to evaluate the relationship between maternal allelic variants in three vitamin D metabolism genes and risk of preeclampsia.
Original paper ↗Read more →Work-Related Musculoskeletal Disorders: A Systematic Review and Meta-Analysis
Musculoskeletal disorders (MSDs) involve muscles, nerves, tendons, joints, cartilage, and spinal discs.
Original paper ↗Read more →Original sources
A structural basis for the unique binding features of the human vitamin D-binding protein
Published in Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C. Nature Structural Biology (2002).
Publication details
A structural basis for the unique binding features of the human vitamin D-binding protein. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C. Nature Structural Biology. 2002;9:131-136.
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein
Published in Safadi FF, Thornton P, Magiera H, et al. Journal of Clinical Investigation (1999).
Publication details
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. Safadi FF, Thornton P, Magiera H, et al. Journal of Clinical Investigation. 1999;103:239-251.
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3
Published in Nykjaer A, Dragun D, Walther D, et al. Proceedings of the National Academy of Sciences USA (2001).
Publication details
Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D3. Nykjaer A, Dragun D, Walther D, et al. Proceedings of the National Academy of Sciences USA. 2001;98:13895-13900.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene
Published in Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine (2019).
Publication details
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene. Henderson CM, Fink SL, Bassyouni H, et al. New England Journal of Medicine. 2019;380:1150-1157.